Tabula Rasa HealthCare, Inc. Income Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of operations

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue
Product
Service
Medication
Technology-enabled solutions
Total revenue
Cost of revenue, exclusive of depreciation and amortization
Product
Service
Medication
Technology-enabled solutions
Total cost of revenue, exclusive of depreciation and amortization
Operating expenses:
Research and development
Sales and marketing
General and administrative
Intangible asset impairment charge
Change in fair value of acquisition-related contingent consideration expense
Change in fair value of contingent consideration receivable
Long-lived asset impairment charge
Depreciation and amortization
Total operating expenses
Loss from operations
Interest expense, net
Other income (expense):
Interest expense, net
Other income
Total other expense, net
Loss from continuing operations before income taxes
Income tax expense (benefit)
Net loss from continuing operations
Net loss from discontinued operations, net of tax
Net loss
Net loss per share, basic and diluted (in dollars per share)
Weighted average common shares outstanding, basic and diluted (in shares)
Net loss per share:
Net loss per share from continuing operations, basic (in dollars per share)
Net loss per share from discontinued operations, basic (in dollars per share)
Total net loss per share, basic (in dollars per share)
Net loss per share from continuing operations, diluted (in dollars per share)
Net loss per share from discontinued operations, diluted (in dollars per share)
Total net loss per share, diluted (in dollars per share)
Weighted average common shares outstanding:
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments